Virtual reality in breast cancer patients: a scoping review
10.3760/cma.j.cn115682-20240510-02598
- VernacularTitle:虚拟现实技术在乳腺癌患者中应用的范围综述
- Author:
Ying GUO
1
;
Fuli ZHAO
1
;
Yaning ZHOU
1
;
Min LIU
1
;
Xueqi TIAN
1
Author Information
1. 山东第一医科大学附属省立医院乳腺甲状腺外科，济南 250000
- Publication Type:Journal Article
- Keywords:
Review;
Virtual reality technology;
Breast neoplasms
- From:
Chinese Journal of Modern Nursing
2025;31(3):405-410
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To conduct a scope review of relevant studies on the application of virtual reality (VR) technology in breast cancer patients, identifying the basic content of interventions, outcome indicators, and application effects, with the aim of providing a reference for clinical healthcare professionals applying this technology.Methods:Based on the research methodology for scope reviews, a computer search was conducted in Chinese and English databases, including China National Knowledge Infrastructure, Wanfang Database, VIP, China Biology Medicine disc, PubMed, Web of Science, Cochrane Library, and Embase, with the search period extending to August 31, 2023. A categorical analysis of the included literature was conducted.Results:A total of 15 articles were included, primarily discussing the effects of VR technology on breast cancer patients' physical health, psychological well-being, cognitive function, and quality of life. Intervention frequencies were mainly once or twice daily, or twice weekly, with intervention durations ranging from 10 to 90 minutes and intervention periods from 2 to 12 weeks. VR interventions were found to improve physical function, psychological health, and cognitive function to some extent, increase patient rehabilitation adherence and satisfaction, and improve quality of life.Conclusions:VR technology can be an effective tool to support the treatment of breast cancer patients. However, the design of intervention protocols needs improvement. Future large-sample, multi-center, long-term follow-up randomized controlled trials are needed to verify the application effects of VR technology for breast cancer patients and promote its clinical application.
